关于未诊断的罕见疾病的全球调查:前景,挑战和解决方案
Simone Baldovino1, Savino Sciascia1, Claudio Carta2
1Center of Excellence on Nephrologic, Rheumatologic, and Rare Diseases (ERK-Net, ERN-Reconnect, and RITA-ERN Member) with Nephrology and Dialysis Unit, Coordinating Center of Piedmont, Valle d'Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.
未诊断的罕见病 (URD) 构成了全球性挑战,需要采取统一的方法. 加强国际合作和资源共享对于改善URD患者的诊断和护理至关重要.
科学领域:
- 罕见疾病诊断 罕见疾病诊断
- 全球卫生挑战 全球卫生挑战
- 基因组医学是一种基因组医学.
背景情况:
- 未诊断的罕见病 (URD) 带来了复杂的挑战,特别是在低收入和中等收入国家.
- 患有URD的个体表现出独特的临床特征,没有确定的诊断.
- 国际未诊断疾病网络 (UDNI) 对URD的定义虽然未被普遍采用,但得到广泛认可.
研究的目的:
- 探索与未诊断的罕见病 (URD) 相关的挑战.
- 确定改善URDs诊断和管理的潜在解决方案.
- 评估UDNI成员和国际参与者对URDs的观点.
主要方法:
- 在未诊断疾病国际网络 (UDNI) 的成员和来自其他国家的参与者中进行了自愿调查.
- 该调查旨在收集有关URD个体遇到困难的见解,并探索可能的解决方案.
主要成果:
- 确定了普遍接受的URD定义的需要,尽管UDNI定义被认为是一个有价值的框架.
- 各国在专业中心和先进的基因组测序 (整个外因组测序和整个基因组测序) 的可用性方面存在显著差异.
- 倡导团体对于支持生活在 URD (PLURD) 的人来说至关重要.
结论:
- 统一的全球承诺至关重要,以优先考虑URD在卫生议程上,得到专门资金和国家战略的支持.
- 国际合作对于全球URD的公平诊断和管理至关重要.
- 利用倡导团体作为盟友的潜力,可以大大帮助解决URD的挑战.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
相关概念视频
Principles of Disease Surveillance
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Case Studies
